vaccine Archives | Page 6 of 8

Home / Posts tagged vaccine (Page 6)

Novavax Initiates Phase 1/2 Clinical Trial of COVID-19 Vaccine

GAITHERSBURG, Md., May 25 (Korea Bizwire) — Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced enrollment of the first participants in a Phase 1/2 clinical trial of its coronavirus vaccine candidate, NVX‑CoV2373, a stable, prefusion protein made using its proprietary nanoparticle technology. NVX‑CoV2373 includes Novavax’ proprietary [...]

Bill & Melinda Gates Foundation Invests in S. Korean Companies Developing Virus Vaccine

SEOUL, May 19 (Korea Bizwire) – South Korean companies have received funds from the Bill & Melinda Gates Foundation, one of the world’s largest private foundations, to research treatment for COVID-19 after South Korea became a model case in containing the pandemic, with high potential in the information technology (IT) and biopharma industries. SK Bioscience, a local [...]

Novavax to Receive Up to $388 Million Funding from CEPI for COVID-19 Vaccine Development and Manufacturing

GAITHERSBURG, Md., May 11 (Korea Bizwire) — Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced that the Coalition for Epidemic Preparedness Innovations (CEPI) will invest up to $384 million of additional funding, on top of $4 million it invested in March, to advance clinical development of [...]

Novavax to Present COVID-19 Vaccine Candidate Progress in World Vaccine Congress Webinar Series

GAITHERSBURG, Md., May 11 (Korea Bizwire) — Novavax, Inc. (Nasdaq: NVAX), a late stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced that Gregory Glenn, M.D., President of Research and Development, will present progress of NVX-CoV2373, Novavax’ coronavirus vaccine candidate, on Wednesday, May 13, 2020 as part of the World Vaccine Congress’ [...]

S. Korea to Shorten Approval Process to Help Develop Coronavirus Vaccine, Treatment

SEOUL, April 24 (Korea Bizwire) — South Korea said Friday it will shorten an approval process later this month for clinical trials and research for experimental vaccines and treatment to combat the novel coronavirus. Under the move, an approval process will be shortened to less than a week from the current one or two months, [...]

Dynavax and Sinovac Announce Collaboration to Develop a Coronavirus (COVID-19) Vaccine

EMERYVILLE, Calif., April 16 (Korea Bizwire) – Dynavax Technologies Corporation (Nasdaq: DVAX), a biopharmaceutical company focused on developing and commercializing novel vaccines, and Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today announced that they have entered into a collaboration to develop a vaccine to prevent COVID-19. The collaboration will evaluate the combination of [...]

Moon, Gates Agree on Coronavirus Vaccines, Treatment in Phone Talks

SEOUL, April 10 (Korea Bizwire) — President Moon Jae-in and Microsoft co-founder Bill Gates agreed Friday to expand cooperation in efforts to develop vaccines and treatments against the new coronavirus during their phone talks, Cheong Wa Dae said. In their 25-minute conversation, made at Gates’ request, they focused on ways to tackle COVID-19 sweeping through [...]

Novavax Identifies Coronavirus Vaccine Candidate; Accelerates Initiation of First-in-Human Trial to Mid-May

GAITHERSBURG, Md., April 8 (Korea Bizwire) — Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced it has identified a coronavirus vaccine candidate, NVX-CoV2373, a stable, prefusion protein made using Novavax’ proprietary nanoparticle technology, and will initiate a first-in-human trial in mid-May. Novavax’ proprietary Matrix-M™ adjuvant will [...]

Dynavax and CEPI Announce Collaboration to Support Global Effort to Develop a Vaccine for Coronavirus (COVID-19)

EMERYVILLE, Calif., March 26 (Korea Bizwire) – Dynavax Technologies Corporation (Nasdaq: DVAX), a biopharmaceutical company focused on developing and commercializing novel vaccines, and the Coalition for Epidemic Preparedness Innovations (CEPI) today announced a collaboration supporting the global effort to develop a vaccine to prevent the coronavirus (COVID-19). Dynavax will make the Company’s proprietary toll-like receptor 9 (TLR9) agonist adjuvant, [...]

Dynavax and Clover Biopharmaceuticals Announce Research Collaboration to Evaluate Coronavirus (COVID-19) Vaccine Candidate with CpG 1018 Adjuvant

EMERYVILLE, Calif. and CHENGDU, China, March 24 (Korea Bizwire) – Dynavax Technologies Corporation (Nasdaq: DVAX), a biopharmaceutical company focused on developing and commercializing novel vaccines, and Clover Biopharmaceuticals, a China-based global clinical-stage biotechnology company focused on developing novel and transformative biologic therapies, today announced that they have entered into a research collaboration to develop a vaccine candidate to [...]